APA

Lenders M., Stappers F., Niemietz C., Schmitz B., Boutin M., Ballmaier P. J., Zibert A., Schmidt H., Brand S., Auray-Blais C. & Brand E. (20200603). Mutation-specific Fabry disease patient-derived cell model to evaluate the amenability to chaperone therapy. : Journal of medical genetics.

Chicago

Lenders Malte, Stappers Franciska, Niemietz Christoph, Schmitz Boris, Boutin Michel, Ballmaier Paula Johanna, Zibert Andree, Schmidt Hartmut, Brand Stefan-Martin, Auray-Blais Christiane and Brand Eva. 20200603. Mutation-specific Fabry disease patient-derived cell model to evaluate the amenability to chaperone therapy. : Journal of medical genetics.

Harvard

Lenders M., Stappers F., Niemietz C., Schmitz B., Boutin M., Ballmaier P. J., Zibert A., Schmidt H., Brand S., Auray-Blais C. and Brand E. (20200603). Mutation-specific Fabry disease patient-derived cell model to evaluate the amenability to chaperone therapy. : Journal of medical genetics.

MLA

Lenders Malte, Stappers Franciska, Niemietz Christoph, Schmitz Boris, Boutin Michel, Ballmaier Paula Johanna, Zibert Andree, Schmidt Hartmut, Brand Stefan-Martin, Auray-Blais Christiane and Brand Eva. Mutation-specific Fabry disease patient-derived cell model to evaluate the amenability to chaperone therapy. : Journal of medical genetics. 20200603.